Close Menu

Lung Cancer

News and reporting on lung cancer.

Opko Health last week presented data at the Alzheimer's Association International Conference in Vancouver demonstrating that its antibody-based Alzheimer's diagnostic identified cases of the disease with 100 percent specificity in a set of 36 autopsy-confirmed plasma samples.

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute wants to see more pulmonary researchers applying 'omics data and genomics-based knowledge to lung disease studies, and plans to fund a new program to train young investigators in using such approaches.

Cepheid Launches Standardized Xpert BCR-ABL Monitor Test
Cepheid has released an updated version of its Xpert BCR-ABL Monitor test, which now incorporates "lot-specific standardization" based on World Health Organization BCR-ABL guidelines.

Rosetta Genomics has published data validating its miRview Lung assay as a means to differentiate between the four main types of lung cancer.

Tegal, a publicly held company previously involved in the application of semiconductor and microelectromechanical systems technology, is shifting its strategic focus to the genomic medicine space by merging with healthcare information technology firm CollabRx.

NEW YORK (GenomeWeb News) – Rosetta Genomics on Monday filed a preliminary prospectus with the US Securities and Exchange Commission for a public offering of common stock aimed at raising up to $35 million.

NEW YORK (GenomeWeb News) – Kreatech Diagnostics and Oridis Biomarkers today said that they will co-develop and commercialize DNA-FISH assays for oncology applications.

Clinical proteomics firm Expression Pathology has changed its name to OncoPlex Diagnostics and opened a CLIA laboratory in Rockville, Md.

NEW YORK (GenomeWeb News) – Insight Genetics and Kindstar Globalgene Technology announced Thursday evening a licensing deal for the Insight ALK Screen lung cancer test.

NEW YORK (GenomeWeb News) – Clarient Diagnostic Services today said that it has licensed worldwide rights from Insight Genetics to intellectual property covering the anaplastic lymphoma kinase biomarker.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.